AI CuratorAI-generated

Research summary · 4 h ago

AI summary · not yet reviewedHuman studyObservationalPublished in a peer-reviewed journal

Multiple Sclerosis Mortality and Incidence Trends in the Middle East and North Africa

This study analyzed changes in multiple sclerosis (MS) mortality, incidence, and prevalence between the Middle East and North Africa (MENA) and global populations from 1990 to 2023. The findings revealed that while the global age-standardized mortality rate (ASMR) decreased, MENA's ASMR increased. Additionally, MS incidence and prevalence rates rose more sharply in MENA compared to global figures.

Tags: #MSResearch
Most relevant to: —
Source: Read original source (PMID 42962632)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Human efficacy: Not established from this source
Mechanism: Not reported
Evidence strength: Limited
Outcome: Negative

Why it matters

These results indicate a growing burden of MS in the MENA region, particularly among females, highlighting an area of public health concern that could impact healthcare resources and policy.

What this does not prove

Uncertainty exists in the MENA ASMR estimates as the GBD (Global Burden of Disease) uncertainty interval included zero. These findings do not establish a cause-and-effect relationship and rely on observational data.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Observational
Participants / samples: Not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-10-26
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified
Biological target: Not reported
Pathway: Not reported
Population: Not reported
Size of effect: Not reported
Secondary endpoints: Not reported
MRI endpoints: Not reported
Biomarkers: Not reported
Safety: Not reported

Original sources

Primary evidenceMultiple sclerosis burden: global versus MENA region (1990 to 2023), with mortality projections to 2050: A pairwise GBD analysis. ↗DOI: 10.1016/j.msard.2026.108028

Supporting passages (9)

study phasePublication types: Journal Article

study designINTRODUCTION: Multiple sclerosis (MS) burden is rising in the Middle East and North Africa (MENA), a region long considered low-prevalence.

subjectsThis study compared MS mortality, incidence, and prevalence between MENA and global populations from 1990 to 2023.

speciesINTRODUCTION: Multiple sclerosis (MS) burden is rising in the Middle East and North Africa (MENA), a region long considered low-prevalence.

peer reviewedPublication types: Journal Article

findingsMENA incidence (AAPC +0.33% vs -0.03%) and prevalence (+0.54% vs +0.26%) outpaced global rates, and female mortality in MENA outpaced male mortality (+2.22% vs +0.97%).

limitationsRESULTS: Global ASMR declined from 0.23 to 0.21 per 100,000 (AAPC -0.28%), whereas MENA ASMR rose from 0.14 to 0.24 (AAPC +1.67%; p < 0.001 versus global), although its GBD uncertainty interval included zero.

outcomeRising deaths in both populations largely reflect population growth and ageing.

publication datePublication date: 2026-10-26

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.